Pharmacore secures funding to improve medication regimen reviews in long-term care Wintermar Offshore (WINS:JK) Public Expose 2023
JAKARTA, Jun 16, 2023 – (ACN Newswire) – PT Wintermar Offshore Marine Tbk (WINS:JK) invested…
Sri Trang Agro-Industry (SET:STA) Expands Business in Ivory Coast
BANGKOK, Jun 16, 2023 – (ACN Newswire) – Sri Trang Agro-Industry PCL (SET: STA), the…
ThetaRay and Millennium EBS Forge Strategic Partnership to Revolutionize Compliance Solutions for Financial Institutions
With digital payment transactions continuing to rapidly grow AI-powered AML technology is critical to effective…
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
MINNEAPOLIS–(BUSINESS WIRE)–On June 12, 2023, FOXO Technologies Inc. (NYSEAM: FOXO) (the “Company”) received an official…
Eminence Capital Sends Open Letter to Entain Board of Directors Following Value Destructive Equity Offering
NEW YORK–(BUSINESS WIRE)–Eminence Capital, LP (“Eminence,” “we” or “us”) today issued the following open letter…
Biotech Executive Michael Smith Discusses the FDA Drug Development Process with CancerVAX CEO Ryan Davies
Michael Smith comments on the growth of immunotherapy and sees the required FDA development phases…
Bavarian Nordic Reports 12-Month Durability Data from a Phase 2 Clinical Trial of its COVID-19 Vaccine Candidate
COPENHAGEN, Denmark, June 16, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today the results…
FDA approves Roche’s Columvi, the first and only bispecific antibody with a fixed-duration treatment for people with relapsed or refractory diffuse large B-cell lymphoma
Pivotal study showed durable responses, with a 56% overall response rate, a 43% complete response…
Web3 Gaming Platform PlayMining Announces ‘SOUL Fusers’ Summer 2023 Launch, Tied in with 4 Project Collaborations
Four project collaborations will support the SOUL Fusers launch: a collaborative IP creation project, a…
My Tooth Media Announces Content Marketing Solutions for LA Dental Practices
My Tooth Media recently announced a range of content marketing services created for dental practices…
AI for Engaging Visual Content: New Marketing Guide Launched by ScottHall.co
ScottHall.co, the company of Scott Hall, a New York-based digital marketing specialist, has released a…
Asia’s Banking, Payments, E-Commerce and Retail Leaders to Gather in Singapore this Month for the First Time in More Than Four Years at Seamless Asia
Seamless Asia, the leading annual gathering of Asia’s commerce leaders, will take place in Singapore…
Elliptic Labs Signs New Contract with a New Leading PC/Laptop Customer
OSLO, Norway–(BUSINESS WIRE)–#AIVirtualPresenceSensor—Elliptic Labs (OSE: ELABS), a global AI software company and the world leader…
Praxis Precision Medicines, Inc. Announces Pricing of $59.1 Million Public Offering
BOSTON, June 15, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma
78% Overall Response Rate (14/18 patients), including seven patients exhibiting a complete response to TT11X…
Xiaomi 13 Ultra, Co-Engineered with Leica, Officially Available in Western Europe from June 12th
London, United Kingdom–(Newsfile Corp. – June 15, 2023) – After the extraordinary success in China,…
American Aires Announces Proposed Offering and Initial Closing
Toronto, Ontario–(Newsfile Corp. – June 15, 2023) – American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF)…
Macnica provides motor-specific predictive maintenance services in Asian countries : Mpression Smart Motor Sensor in ASEAN
– Reducing downtime and optimizing maintenance costs for customers in the manufacturing industry – YOKOHAMA,…
PsiQuantum publishes paper projecting a 700x reduction in the computational resource requirements for breaking Elliptic Curve Cryptography using a fault tolerant quantum computer
PsiQuantum’s latest paper describes a more efficient method to break Elliptic Curve Cryptography (ECC) which…
HUTCHMED and Takeda Announce Publication of Phase III FRESCO-2 Results in The Lancet
— Publication shows FRESCO-2 demonstrated treatment with fruquintinib reduced the risk of death by 34%…